Cybin (HELP) Exchange Rate Effect (2020 - 2026)
Cybin (HELP) posted quarterly Exchange Rate Effect of -$87000.0 for Q1 2026, down 140.07% year-on-year from $217128.2 in Q1 2025, and down 107.14% on a QoQ basis from -$42000.0 in Q4 2025.
Cybin (HELP) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Exchange Rate Effect for 7 consecutive years, with -$87000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 140.07% year-over-year to -$87000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$269000.0 (up 64.1% YoY) and the FY2026 annual result came in at -$269000.0, up 60.84% from the prior year.
- Exchange Rate Effect slipped to -$87000.0 in Q1 2026 per HELP's latest filing, from -$42000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for HELP reached as high as $145681.8 in Q3 2022 and fell as low as -$1.9 million in Q2 2022.
- A 5-year average of -$185072.8 and a median of -$42000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 6012.79% — and 2023, when it slumped 399.12%.
- Year by year, Exchange Rate Effect stood at $68513.4 in 2022, then plunged by 399.12% to -$204935.4 in 2023, then slumped by 223.03% to -$662000.0 in 2024, then soared by 93.66% to -$42000.0 in 2025, then tumbled by 107.14% to -$87000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$87000.0, -$42000.0, and -$46000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | -87,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Mar 31, 2025 | -36,239.66 |
| Mar 31, 2025 | -36,239.66 |
| Dec 31, 2024 | -662,000.00 |
| Dec 31, 2024 | -662,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | 40,074.11 |
| Mar 31, 2024 | 40,074.11 |
| Dec 31, 2023 | -204,935.41 |
| Dec 31, 2023 | -204,935.41 |